Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2701)
All Articles published online
|
May 28, 2007 (publication date) through Nov 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Charoentum C, Thongprasert S, Chewaskulyong B, Munprakan S. Experience with gemcitabine and cisplatin in the therapy of inoperable and metastatic cholangiocarcinoma. World J Gastroenterol 2007; 13(20): 2852-2854 [PMID: 17569122 DOI: 10.3748/wjg.v13.i20.2852] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i20/2852.htm |
| Number | Citing Articles |
| 1 |
Kritiya Butthongkomvong, Ekaphop Sirachainan, Supattra Jhankumpha, Surang Kumdang, On-Usa Sukhontharot. Treatment Outcome of Palliative Chemotherapy in Inoperable Cholangiocarcinoma in Thailand. Asian Pacific Journal of Cancer Prevention 2013; 14(6): 3565 doi: 10.7314/APJCP.2013.14.6.3565
|
| 2 |
Guido Poggi, A. Amatu, B. Montagna, P. Quaretti, C. Minoia, C. Sottani, L. Villani, B. Tagliaferri, F. Sottotetti, O. Rossi, E. Pozzi, F. Zappoli, A. Riccardi, G. Bernardo. OEM-TACE: A New Therapeutic Approach in Unresectable Intrahepatic Cholangiocarcinoma. CardioVascular and Interventional Radiology 2009; 32(6): 1187 doi: 10.1007/s00270-009-9694-4
|
| 3 |
T Okusaka, K Nakachi, A Fukutomi, N Mizuno, S Ohkawa, A Funakoshi, M Nagino, S Kondo, S Nagaoka, J Funai, M Koshiji, Y Nambu, J Furuse, M Miyazaki, Y Nimura. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. British Journal of Cancer 2010; 103(4): 469 doi: 10.1038/sj.bjc.6605779
|
| 4 |
Dejuan Kong, Shumei Ma, Bing Liang, Heqing Yi, Yinlong Zhao, Rui Xin, Li Cui, Lili Jia, Xin Liu, Xiaodong Liu. The different regulatory effects of p53 status on multidrug resistance are determined by autophagy in ovarian cancer cells. Biomedicine & Pharmacotherapy 2012; 66(4): 271 doi: 10.1016/j.biopha.2011.12.002
|
| 5 |
Niranjan Vijayaraghavan, Rakesh MP, Latha KVS. Treatment Outcomes of Advanced Cholangiocarcinoma: A Single-Center Experience from India. South Asian Journal of Cancer 2022; 11(01): 036 doi: 10.1055/s-0041-1730889
|
| 6 |
Tian-Tian Sun, Ji-Lin Wang, Jing-Yuan Fang. Gemcitabine Alone or in Combination with Cisplatin for Advanced Biliary Tract Carcinomas: an Overview of Clinical Evidence. Asian Pacific Journal of Cancer Prevention 2013; 14(2): 877 doi: 10.7314/APJCP.2013.14.2.877
|
| 7 |
Bing Liang, Xiaodong Liu, Yang Liu, Dejuan Kong, Xiaomei Liu, Rui Zhong, Shumei Ma. Inhibition of autophagy sensitizes MDR-phenotype ovarian cancer SKVCR cells to chemotherapy. Biomedicine & Pharmacotherapy 2016; 82: 98 doi: 10.1016/j.biopha.2016.04.054
|
| 8 |
Jin Hyoung Kim, Hyun‐Ki Yoon, Kyu‐Bo Sung, Gi‐Young Ko, Dong Il Gwon, Ji Hoon Shin, Ho‐Young Song. Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma. Cancer 2008; 113(7): 1614 doi: 10.1002/cncr.23787
|
| 9 |
Jaekyung Cheon, Choong-kun Lee, Yun Beom Sang, Hye Jin Choi, Min Hwan Kim, Jun Ho Ji, Kwang Hyun Ko, Chang-Il Kwon, Dae Jung Kim, Sung Hoon Choi, Chan Kim, Beodeul Kang, Hong Jae Chon. Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis. Therapeutic Advances in Medical Oncology 2021; 13 doi: 10.1177/17588359211035983
|
| 10 |
Frédéric Fiteni, Thierry Nguyen, Dewi Vernerey, Marie‐Justine Paillard, Stefano Kim, Martin Demarchi, Francine Fein, Christophe Borg, Franck Bonnetain, Xavier Pivot. Cisplatin/gemcitabine or oxaliplatin/gemcitabine in the treatment of advanced biliary tract cancer: a systematic review. Cancer Medicine 2014; 3(6): 1502 doi: 10.1002/cam4.299
|
| 11 |
Donatella Marino, Francesco Leone, Giuliana Cavalloni, Celeste Cagnazzo, Massimo Aglietta. Biliary tract carcinomas: From chemotherapy to targeted therapy. Critical Reviews in Oncology/Hematology 2013; 85(2): 136 doi: 10.1016/j.critrevonc.2012.06.006
|
| 12 |
Marcus Wiedmann, Helmut Witzigmann, Joachim Mössner. Clinical Hepatology. 2010; : 1519 doi: 10.1007/978-3-642-04519-6_62
|
| 13 |
Manuela Gatto, Maria Consiglia Bragazzi, Rossella Semeraro, Cristina Napoli, Raffaele Gentile, Alessia Torrice, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinoma: Update and future perspectives. Digestive and Liver Disease 2010; 42(4): 253 doi: 10.1016/j.dld.2009.12.008
|
| 14 |
Junji Furuse, Takuji Okusaka, John Bridgewater, Masanori Taketsuna, Harpreet Wasan, Minori Koshiji, Juan Valle. Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer. Critical Reviews in Oncology/Hematology 2011; 80(1): 31 doi: 10.1016/j.critrevonc.2010.10.009
|
| 15 |
Jonathan P. Pearl, Jeffrey L. Ponsky. Minimally Invasive Surgical Oncology. 2011; : 253 doi: 10.1007/978-3-540-45021-4_20
|
| 16 |
Eun-Young Kim, Sang Soo Lee, Ji Hoon Shin, Soo Hyun Kim, Dong-Ho Shin, Seung Yon Baek. Anticancer effect of arsenic trioxide on cholangiocarcinoma: in vitro experiments and in vivo xenograft mouse model. Clinical and Experimental Medicine 2014; 14(2): 215 doi: 10.1007/s10238-013-0233-x
|